Vergoeding 2015-2019 voor ATC-subgroep N05AX : Overige antipsychotica
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| N05AX08 Risperidon (Risperdal ®) | 6.288.000 | 5.799.100 | 5.064.700 | 4.642.600 | 4.584.600 |
| N05AX12 Aripiprazol (Abilify maintena ®) | 22.442.800 | 16.117.300 | 10.797.300 | 10.434.100 | 11.168.300 |
| N05AX13 Paliperidon (Xeplion ®) | 7.759.100 | 8.632.000 | 9.816.100 | 10.568.400 | 11.723.200 |
| N05AX15 Cariprazine (Reagila ®) | . | . | . | 4.180 | 150.870 |
| N05AX16 Brexpiprazol (Rxulti ®) | . | . | . | . | 38.014 |
| Totaal | 36.489.900 | 30.548.400 | 25.678.100 | 25.649.280 | 27.664.984 |